These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 10604326)

  • 41. Growth factor, cytokine, and vitamin D receptor polymorphisms and risk of benign prostatic hyperplasia in a community-based cohort of men.
    Mullan RJ; Bergstralh EJ; Farmer SA; Jacobson DJ; Hebbring SJ; Cunningham JM; Thibodeau SN; Lieber MM; Jacobsen SJ; Roberts RO
    Urology; 2006 Feb; 67(2):300-5. PubMed ID: 16461080
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Accelerated longitudinal decline of aerobic capacity in healthy older adults.
    Fleg JL; Morrell CH; Bos AG; Brant LJ; Talbot LA; Wright JG; Lakatta EG
    Circulation; 2005 Aug; 112(5):674-82. PubMed ID: 16043637
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Tamsulosin for treating lower urinary tract symptoms compatible with benign prostatic obstruction: a systematic review of efficacy and adverse effects.
    Wilt TJ; MacDonald R; Nelson D
    J Urol; 2002 Jan; 167(1):177-83. PubMed ID: 11743300
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diabetes and sexual dysfunction: results from the Olmsted County study of urinary symptoms and health status among men.
    Burke JP; Jacobson DJ; McGree ME; Nehra A; Roberts RO; Girman CJ; Lieber MM; Jacobsen SJ
    J Urol; 2007 Apr; 177(4):1438-42. PubMed ID: 17382749
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lower urinary tract symptoms, prostate volume and uroflow in norwegian community men.
    Overland GB; Vatten L; Rhodes T; DeMuro C; Jacobsen G; Vada K; Angelsen A; Girman CJ
    Eur Urol; 2001 Jan; 39(1):36-41. PubMed ID: 11173937
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Doxazosin in the gastrointestinal therapeutic system (GITS) and doxazosin standard in patients with benign prostatic hyperplasia. Double-blind trial of efficacy and tolerability].
    Gratzke P; Kirby RS
    Fortschr Med Orig; 2000 Jul; 118 Suppl 2():83-92. PubMed ID: 15700491
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Response to daily 10 mg alfuzosin predicts acute urinary retention and benign prostatic hyperplasia related surgery in men with lower urinary tract symptoms.
    Emberton M; Lukacs B; Matzkin H; Alcaraz A; Elhilali M; Vallancien G
    J Urol; 2006 Sep; 176(3):1051-6. PubMed ID: 16890690
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the International Prostate Symptom Score.
    Itoh H; Kojima M; Okihara K; Ukimura O; Ushijima S; Kawauchi A; Miki T
    Int J Urol; 2006 Aug; 13(8):1058-65. PubMed ID: 16903930
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prostatic growth rate determined from MRI data: age-related longitudinal changes.
    Williams AM; Simon I; Landis PK; Moser C; Christens-Barry W; Carter HB; Metter EJ; Partin AW
    J Androl; 1999; 20(4):474-80. PubMed ID: 10452590
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Natural history of prostatism: urinary flow rates in a community-based study.
    Girman CJ; Panser LA; Chute CG; Oesterling JE; Barrett DM; Chen CC; Arrighi HM; Guess HA; Lieber MM
    J Urol; 1993 Sep; 150(3):887-92. PubMed ID: 7688433
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Distribution of post-void residual urine volume in randomly selected men.
    Kolman C; Girman CJ; Jacobsen SJ; Lieber MM
    J Urol; 1999 Jan; 161(1):122-7. PubMed ID: 10037383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cigarette smoking and prostatism: a biphasic association?
    Roberts RO; Jacobsen SJ; Rhodes T; Guess HA; Girman CJ; Panser LA; Chute CG; Oesterling JE; Lieber MM
    Urology; 1994 Jun; 43(6):797-801. PubMed ID: 7515203
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Limitations of using outcomes in the placebo arm of a clinical trial of benign prostatic hyperplasia to quantify those in the community.
    Roberts RO; Lieber MM; Jacobson DJ; Girman CJ; Jacobsen SJ
    Mayo Clin Proc; 2005 Jun; 80(6):759-64. PubMed ID: 15948299
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Longitudinal changes in post-void residual and voided volume among community dwelling men.
    Rule AD; Jacobson DJ; McGree ME; Girman CJ; Lieber MM; Jacobsen SJ
    J Urol; 2005 Oct; 174(4 Pt 1):1317-21; discussion 1321-2; author reply 1322. PubMed ID: 16145411
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does Peak Urine Flow Rate Predict the Development of Incident Lower Urinary Tract Symptoms in Men with Mild to No Current Symptoms? Results from REDUCE.
    Simon RM; Howard LE; Moreira DM; Roehrborn C; Vidal A; Castro-Santamaria R; Freedland SJ
    J Urol; 2017 Sep; 198(3):650-656. PubMed ID: 28428110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary flow patterns in first year of life.
    Olsen LH; Grothe I; Rawashdeh YF; Jørgensen TM
    J Urol; 2010 Feb; 183(2):694-8. PubMed ID: 20022052
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Serum sex hormones and measures of benign prostatic hyperplasia.
    Roberts RO; Jacobson DJ; Rhodes T; Klee GG; Leiber MM; Jacobsen SJ
    Prostate; 2004 Oct; 61(2):124-31. PubMed ID: 15305335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men?
    Jacobsen SJ; Girman CJ; Guess HA; Panser LA; Chute CG; Oesterling JE; Lieber MM
    Urology; 1995 Jan; 45(1):64-9. PubMed ID: 7529448
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Natural history of prostatism: longitudinal changes in voiding symptoms in community dwelling men.
    Jacobsen SJ; Girman CJ; Guess HA; Rhodes T; Oesterling JE; Lieber MM
    J Urol; 1996 Feb; 155(2):595-600. PubMed ID: 8558668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Analysis of site differences in voiding condition of elderly men-- comparison to results of mass screening for prostate diseases between the villages of Shimamaki-mura, Hokkaido and Satomi-Mura, Ibaraki].
    Masumori N; Tsukamoto T; Tanaka Y; Kumamoto Y; Ishikawa S; Akaza H; Koiso K
    Hinyokika Kiyo; 1996 Aug; 42(8):557-61. PubMed ID: 8889562
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.